Skip to content
Menu

Head-to-head comparison

Kova vs TeleCareSpot

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #158Desk pick
Kova

Kova is a 50-state GLP-1 weight-loss program from LifeTech Apps Inc, a Delaware company, selling compounded semaglutide and tirzepatide — injectable or oral — with the medication included in the plan price and a companion app that tracks weight, protein intake and side effects.

$299/mo sema · $399/mo tirz · Verified August 2026

Marked down on: At $299 and $399 a month, the standing month-to-month rates are among the dearest compounded GLP-1 options we track — the low figures all require a three-, six- or twelve-month commitment paid or billed in full

vs
Ranked #169
TeleCareSpot

TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat.

$299/mo (+ membership fee) sema · $399/mo tirz · Verified June 2026

Marked down on: The LegitScript seal ID this provider publishes, #45936855, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass

Kova takes this head-to-head with the higher Desk Score, 72/100 (C) against 71/100 (C) for TeleCareSpot. TeleCareSpot still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Kova

72/100

C

Overall

TeleCareSpot

71/100

C

Price transparency

68
46

State access

86
78

Molecule range

77
77

Onboarding speed

64
78

Support responsiveness

68
76

Licensing & trust

60
93

The spec sheet

FieldKovaTeleCareSpot
Semaglutide$299/mo$299/mo month-to-month ($249 for the first month); $179/mo on a 3-month plan ($537 up front); $149/mo on a 6-month plan ($894 up front); $129/mo on a 12-month plan ($1,548 up front); medication included; compounded$299/mo+ membership fee$299/mo (all doses, plus a separate fee, compounded)
Tirzepatide$399/mo$399/mo month-to-month ($299 for the first month); $249/mo on a 3-month plan ($747 up front); $229/mo on a 6-month plan ($1,374 up front); $199/mo on a 12-month plan ($2,388 up front); medication included; compounded$399/mo$399/mo
CoverageAll 50 states48 states
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forPeople who want compounded semaglutide or tirzepatide with the medication included in one price, a published four-rung ladder for each, and a tracking app bundled in.Flat-priced compounded semaglutide or tirzepatide with broad state coverage.
Desk Score72/100C71/100C

The verdict

Desk pick — Kova

Kova takes this head-to-head with the higher Desk Score, 72/100 (C) against 71/100 (C) for TeleCareSpot. TeleCareSpot still holds its ground where its strengths line up with yours.

Choose Kova if…

People who want compounded semaglutide or tirzepatide with the medication included in one price, a published four-rung ladder for each, and a tracking app bundled in.

$299/mo sema · $399/mo tirz · All 50 states

Choose TeleCareSpot if…

Flat-priced compounded semaglutide or tirzepatide with broad state coverage.

$299/mo (+ membership fee) sema · $399/mo tirz · 48 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Kova · TeleCareSpot.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.